Vanguard Group Inc. lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 0.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,315,421 shares of the company's stock after purchasing an additional 75,313 shares during the period. Vanguard Group Inc. owned 11.35% of Option Care Health worth $448,118,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the stock. Graypoint LLC bought a new position in Option Care Health during the fourth quarter worth about $1,161,000. Charles Schwab Investment Management Inc. boosted its stake in Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after acquiring an additional 147,054 shares during the last quarter. Global Alpha Capital Management Ltd. grew its holdings in Option Care Health by 38.1% during the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after purchasing an additional 18,992 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in Option Care Health in the fourth quarter valued at approximately $327,000. Finally, Barclays PLC increased its stake in Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after purchasing an additional 199,454 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Stock Down 4.0 %
Shares of Option Care Health stock traded down $1.40 during trading on Friday, reaching $33.54. The stock had a trading volume of 2,392,435 shares, compared to its average volume of 1,734,150. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.51 billion, a price-to-earnings ratio of 28.18, a P/E/G ratio of 2.30 and a beta of 1.07. The stock has a fifty day moving average price of $32.97 and a two-hundred day moving average price of $28.49. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.
Insider Activity at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on OPCH shares. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Barrington Research increased their price target on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $33.00.
Read Our Latest Stock Report on OPCH
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
